A retrospective multicenter study of changes in biochemical, histopathologic, radiographic, and inflammatory bowel disease activity on vedolizumab therapy in children with primary sclerosing cholangitis-inflammatory bowel disease
Latest Information Update: 08 Jul 2021
At a glance
- Drugs Vedolizumab (Primary)
- Indications Inflammatory bowel diseases; Primary sclerosing cholangitis
- Focus Therapeutic Use
- 08 Jul 2021 New trial record